227 related articles for article (PubMed ID: 18178066)
21. CTX-M-15, OXA-30 and TEM-1-producing Escherichia coli in two Portuguese regions.
Mendonça N; Louro D; Castro AP; Diogo J; Caniça M
J Antimicrob Chemother; 2006 May; 57(5):1014-6. PubMed ID: 16531434
[No Abstract] [Full Text] [Related]
22. Naturally occurring extended-spectrum cephalosporinases in Escherichia coli.
Mammeri H; Poirel L; Fortineau N; Nordmann P
Antimicrob Agents Chemother; 2006 Jul; 50(7):2573-6. PubMed ID: 16801449
[TBL] [Abstract][Full Text] [Related]
23. Reduced susceptibility to cefepime among Escherichia coli clinical isolates producing novel variants of CMY-2 beta-lactamase.
Doi Y; Paterson DL; Adams-Haduch JM; Sidjabat HE; O'Keefe A; Endimiani A; Bonomo RA
Antimicrob Agents Chemother; 2009 Jul; 53(7):3159-61. PubMed ID: 19414578
[TBL] [Abstract][Full Text] [Related]
24. Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan.
Ode T; Saito R; Kumita W; Sato K; Okugawa S; Moriya K; Koike K; Okamura N
Int J Antimicrob Agents; 2009 Oct; 34(4):347-50. PubMed ID: 19560903
[TBL] [Abstract][Full Text] [Related]
25. Characterisation of ceftiofur resistance in swine bacterial pathogens.
Chander Y; Oliveira S; Goyal SM
Vet J; 2011 Jan; 187(1):139-41. PubMed ID: 19914850
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
Pitout JD; Le P; Church DL; Gregson DB; Laupland KB
Int J Antimicrob Agents; 2008 Oct; 32(4):333-8. PubMed ID: 18701262
[TBL] [Abstract][Full Text] [Related]
27. Characterization of OXA-29 from Legionella (Fluoribacter) gormanii: molecular class D beta-lactamase with unusual properties.
Franceschini N; Boschi L; Pollini S; Herman R; Perilli M; Galleni M; Frère JM; Amicosante G; Rossolini GM
Antimicrob Agents Chemother; 2001 Dec; 45(12):3509-16. PubMed ID: 11709332
[TBL] [Abstract][Full Text] [Related]
28. High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution.
Cartelle M; del Mar Tomas M; Molina F; Moure R; Villanueva R; Bou G
Antimicrob Agents Chemother; 2004 Jun; 48(6):2308-13. PubMed ID: 15155242
[TBL] [Abstract][Full Text] [Related]
29. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
Palasubramaniam S; Muniandy S; Navaratnam P
J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
[TBL] [Abstract][Full Text] [Related]
30. [Prevalence of extended-spectrum beta-lactamase producing Escherichia coli in pediatric patients in China].
Wang L; Yang YH; Lu Q; Wang Y; Chen Y; Deng L; Deng QL; Zhang H; Wang CQ; Liu L; Xu XW; Shen XZ
Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1372-5. PubMed ID: 18953872
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Cha R
Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
[TBL] [Abstract][Full Text] [Related]
32. Activity of mecillinam against AmpC beta-lactamase-producing Escherichia coli.
Brenwald NP; Andrews J; Fraise AP
J Antimicrob Chemother; 2006 Jul; 58(1):223-4. PubMed ID: 16698846
[No Abstract] [Full Text] [Related]
33. Cloning and functional characterization of the ambler class C beta-lactamase of Yersinia ruckeri.
Mammeri H; Poirel L; Nazik H; Nordmann P
FEMS Microbiol Lett; 2006 Apr; 257(1):57-62. PubMed ID: 16553832
[TBL] [Abstract][Full Text] [Related]
34. Presence of extended-spectrum β-lactamase-producing Escherichia coli in wild geese.
Garmyn A; Haesebrouck F; Hellebuyck T; Smet A; Pasmans F; Butaye P; Martel A
J Antimicrob Chemother; 2011 Jul; 66(7):1643-4. PubMed ID: 21467083
[No Abstract] [Full Text] [Related]
35. Emerging problems with plasmid-mediated DHA and CMY AmpC beta-lactamases in Enterobacteriaceae in Singapore.
Koh TH; Sng LH; Wang G; Hsu LY; Lin RT; Tee NW
Int J Antimicrob Agents; 2007 Sep; 30(3):278-80. PubMed ID: 17587551
[No Abstract] [Full Text] [Related]
36. Addressing the challenge of extended-spectrum beta-lactamases.
Zahar JR; Lortholary O; Martin C; Potel G; Plesiat P; Nordmann P
Curr Opin Investig Drugs; 2009 Feb; 10(2):172-80. PubMed ID: 19197795
[TBL] [Abstract][Full Text] [Related]
37. Purification and characterization of a beta-lactamase from Haemophilus ducreyi in Escherichia coli.
Lawung R; Prachayasittikul V; Bülow L
Protein Expr Purif; 2001 Oct; 23(1):151-8. PubMed ID: 11570857
[TBL] [Abstract][Full Text] [Related]
38. CMY-2-type plasmid-mediated AmpC beta-lactamase finally emerging in Argentina.
Rapoport M; Monzani V; Pasteran F; Morvay L; Faccone D; Petroni A; Galas M
Int J Antimicrob Agents; 2008 Apr; 31(4):385-7. PubMed ID: 18242960
[No Abstract] [Full Text] [Related]
39. Decreased Resistance to Broad-Spectrum Cephalosporin in Escherichia coli from Healthy Broilers at Farms in Japan After Voluntary Withdrawal of Ceftiofur.
Hiki M; Kawanishi M; Abo H; Kojima A; Koike R; Hamamoto S; Asai T
Foodborne Pathog Dis; 2015 Jul; 12(7):639-43. PubMed ID: 26135895
[TBL] [Abstract][Full Text] [Related]
40. ACT-3, a novel plasmid-encoded class C beta-lactamase in a Klebsiella pneumoniae isolate from China.
Chen Y; Cheng J; Wang Q; Ye Y; Li JB; Zhang XJ
Int J Antimicrob Agents; 2009 Jan; 33(1):95-6. PubMed ID: 18789849
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
